Sewoon Medical Co Ltd
KOSDAQ:100700
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Sewoon Medical Co Ltd
Cash from Operating Activities
Sewoon Medical Co Ltd
Cash from Operating Activities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
S
|
Sewoon Medical Co Ltd
KOSDAQ:100700
|
Cash from Operating Activities
₩16.8B
|
CAGR 3-Years
21%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
11%
|
|
|
Suheung Co Ltd
KRX:008490
|
Cash from Operating Activities
₩76.9B
|
CAGR 3-Years
13%
|
CAGR 5-Years
11%
|
CAGR 10-Years
11%
|
|
|
SD Biosensor Inc
KRX:137310
|
Cash from Operating Activities
₩156.5B
|
CAGR 3-Years
-50%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
B
|
BioPlus Co Ltd
KOSDAQ:099430
|
Cash from Operating Activities
₩22.3B
|
CAGR 3-Years
19%
|
CAGR 5-Years
35%
|
CAGR 10-Years
N/A
|
|
|
H
|
HLB Inc
KOSDAQ:028300
|
Cash from Operating Activities
-₩92.6B
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
N/A
|
|
|
T
|
T&L Co Ltd
KOSDAQ:340570
|
Cash from Operating Activities
₩46.6B
|
CAGR 3-Years
35%
|
CAGR 5-Years
43%
|
CAGR 10-Years
N/A
|
|
Sewoon Medical Co Ltd
Glance View
SEWOONMEDICAL Co. Ltd. engages in the manufacturing of pharmaceutical goods other than medicaments. The company is headquartered in Cheonan, Chungcheongnam-Do. The company went IPO on 2008-09-30. The firm's products portfolio consists of wound drainage systems under the brand name BAROVAC; urinary catheters and tubes, such as silicon foley balloon catheters, latex foley balloon catheters, urinary self-catheters, polyvinyl chloride (PVC) nelaton catheters and others; drainage catheters and tubes, such as external ventricular drainage systems, gastric lavage systems, silicone thoracic catheters, PVC thoracic catheters and others; tracheal tubes, such as silicone endotracheal tubes, silicone tracheostomy tubes, teflon tracheostomy tubes, PVC airways and others, and infusion devices, such as central venous catheter kits, silicone gastric duodenal levin tubes and others.
See Also
What is Sewoon Medical Co Ltd's Cash from Operating Activities?
Cash from Operating Activities
16.8B
KRW
Based on the financial report for Sep 30, 2025, Sewoon Medical Co Ltd's Cash from Operating Activities amounts to 16.8B KRW.
What is Sewoon Medical Co Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
11%
Over the last year, the Cash from Operating Activities growth was 20%. The average annual Cash from Operating Activities growth rates for Sewoon Medical Co Ltd have been 21% over the past three years , -2% over the past five years , and 11% over the past ten years .
